Gallium Nitride, or GaN, is a third-generation semiconductor material and a key representative of wide-bandgap semiconductors. In simple terms, GaN power devices enable faster, more efficient, smaller, and more effective electrical energy conversion.
This technology is finding its way into applications such as fast chargers, power adapters, data center power supplies, electric vehicles, photovoltaic energy storage, and industrial control systems.
Historically, the focus on GaN has centered on technology, production capacity, yield rates, and cost. However, the ongoing global patent dispute between Infineon Technologies AG and INNOSCIENCE serves as a reminder that as GaN commercialization accelerates, patents are moving from the background to the forefront.
The question of whose products can be sold in the United States, whose can be sold in Germany, and whose can be sold in China is being decisively reshaped by patent litigation and court injunctions.
Key Timeline of the Dispute
The patent conflict between Infineon Technologies AG and INNOSCIENCE did not erupt suddenly. It has evolved into a global legal battle spanning multiple jurisdictions, including the United States, Germany, and China.
In March 2024, Infineon Technologies AG initiated the legal offensive by filing a patent infringement lawsuit against INNOSCIENCE in the United States District Court for the Northern District of California, seeking a permanent injunction.
By June 2024, the battleground shifted to Germany, where Infineon Technologies AG filed corresponding lawsuits and sought injunctions against INNOSCIENCE products at the Munich Regional Court, establishing Germany as a primary European theater.
In July 2024, Infineon Technologies AG expanded its U.S. litigation and initiated a Section 337 investigation with the U.S. International Trade Commission, aiming to block the import of allegedly infringing INNOSCIENCE products.
Later in 2024, the conflict reached China. INNOSCIENCE filed two patent infringement lawsuits in the Suzhou Intermediate People's Court against Infineon Technologies AG's Chinese entities, targeting its CoolGaN G3 series products, marking a shift from a defensive to an offensive posture in its home market.
In November 2025, the Chinese patents asserted by INNOSCIENCE were upheld as valid by the China National Intellectual Property Administration, a decision later affirmed by the Beijing Intellectual Property Court, providing a stable legal foundation for INNOSCIENCE to seek injunctions in China.
In May 2026, the U.S. International Trade Commission ruled in favor of Infineon Technologies AG, issuing an import and sales ban on certain INNOSCIENCE products. However, INNOSCIENCE emphasized that its current commercial products were largely unaffected and could continue to be sold in the U.S.
Also in May 2026, the Suzhou Intermediate People's Court issued first-instance judgments supporting INNOSCIENCE, finding Infineon Technologies AG's products infringing, awarding damages, and granting a preliminary injunction to halt sales and imports of the implicated CoolGaN G3 series in China.
On June 12, 2026, the Supreme People's Court of China upheld the Suzhou court's preliminary injunction after Infineon Technologies AG applied for a reconsideration, giving INNOSCIENCE a powerful enforcement tool in the Chinese market.
On June 18, 2026, the Munich Regional Court in Germany ruled partially in favor of Infineon Technologies AG, prohibiting INNOSCIENCE from making, selling, or promoting certain infringing products in Germany. INNOSCIENCE responded that the ruling affected only a limited range of older, discontinued products and did not impact its current commercial GaN power devices.
The resulting landscape is clear: Infineon Technologies AG holds a procedural advantage in the U.S., continues to press for injunctions in Germany, while INNOSCIENCE has secured a significant countermeasure in China. This is not a single-case victory but a complex, multi-jurisdictional global patent war.
Global Market Implications of the Patent Battle
The GaN market is not yet fully mature, which is precisely why this patent war carries significant weight. In a stable, mature industry, patent litigation typically affects royalties, licensing, and specific product lines. GaN, however, is in a rapid commercialization phase across data centers, EVs, solar storage, industrial power, and consumer fast charging.
At this stage, securing a position in customer supply chains, completing product validation, and locking in downstream designs can determine long-term market share. Therefore, an injunction's value extends beyond blocking a single product; it can influence customer sourcing decisions, force design changes, disrupt regional supply stability, and alter negotiation leverage.
This dispute is unique because the parties are contesting a critical gateway for future wide-bandgap semiconductor applications, not just a standard component market. For Infineon Technologies AG, GaN is a vital growth segment in its power semiconductor portfolio, and patents are crucial for protecting its R&D investment and market position. For INNOSCIENCE, GaN is its core pathway into the global power semiconductor market, requiring proof that its products are not only manufacturable and cost-effective but also resilient to major-market IP challenges.
Ultimately, this war is about determining who has the right to expand their share in the global GaN market.
Divergent Injunctions Reshape Market Access
The recent court outcomes in Germany and China have created a classic scenario of cross-border, mutually opposing injunctions. In Germany, Infineon Technologies AG is on the offensive against INNOSCIENCE. In China, INNOSCIENCE has successfully counter-punched against Infineon Technologies AG.
The German injunction restricts INNOSCIENCE's product sales and promotion in the European market. The Chinese injunction blocks the sale, offer for sale, and import of specific Infineon Technologies AG GaN products in China.
This demonstrates that in global semiconductor patent wars, a company is unlikely to be the sole aggressor in every jurisdiction. Infineon Technologies AG is the plaintiff in the U.S. and Germany but the defendant facing an injunction in China. Conversely, INNOSCIENCE is defending against claims in Europe and America while asserting its own patents offensively in China.
This is the reality of global IP warfare: simultaneous博弈 across multiple markets, courts, and patent portfolios. A loss in one market can be balanced by a countermeasure in another. A national injunction becomes a bargaining chip in global negotiations. Adjustments to a single product model can shift the entire litigation narrative. The true significance of this GaN patent war lies not in declaring a simple winner, but in observing how patents are beginning to segment the global market.
The German Ruling: Patents as a Market Access Tool in Europe
Germany has long been a key battleground for European patent litigation due to its important market, relatively efficient courts, and the direct impact of injunction relief on businesses. Infineon Technologies AG's choice to make Germany a primary offensive front is therefore strategic.
As a major hub for industrial manufacturing, automotive electronics, and power semiconductor applications, a German injunction can affect not only local sales but also market confidence among INNOSCIENCE's European customers. Infineon Technologies AG's announcement highlighted the court's support for its GaN patents and the ban on INNOSCIENCE's infringing products.
INNOSCIENCE's response, however, was equally strategic. It did not outright deny the unfavorable ruling but clarified that it applied only to a limited range of older, discontinued products, leaving its current commercial lineup unaffected. This highlights a critical capability in high-tech patent wars: design-around strategies.
If a company can iterate its products to operate outside the scope of asserted patents, a loss on older models may not materially impact current market supply. The German front underscores that effective patent litigation defense requires close collaboration between legal teams and R&D departments for product redesign, model transitions, customer communication, and supply chain stabilization.
A Unified Signal from the Courts
While the German and Chinese legal systems and case stages differ, they collectively send a clear signal: in emerging technology fields like GaN, courts are no longer just post-infringement arbiters of damages; they are willing to use injunctions to directly influence market access.
The German court's support for Infineon Technologies AG demonstrates the real deterrent power of patent injunctions in Europe. The Chinese Supreme Court's upholding of the preliminary injunction shows a willingness to use provisional measures to protect a patent holder's market interests and judgment enforceability in fast-moving technological sectors.
This will influence future semiconductor patent litigation in several ways. First, injunctions will become a central tool in corporate patent strategy, often outweighing the importance of damages in fields like GaN, SiC, and AI chips, as they control future market access.
Second, the focus will shift from patent quantity to patent quality—specifically, patents that can withstand invalidity challenges, cover competitor products, and be converted into injunctions in key jurisdictions.
Third, globalized companies must prepare for simultaneous multi-jurisdictional warfare. A patent portfolio limited to one region is insufficient for global market defense or offense.
Fourth, product development must be closely integrated with IP litigation strategy, as evidenced by INNOSCIENCE's emphasis on unaffected current products. In high-tech disputes, the best defense can sometimes be a new product.
Fifth, downstream customers will increasingly factor IP risk into their supply chain assessments. GaN devices are intermediate components; if banned, replacing them in end-systems like servers, EVs, or industrial power supplies incurs significant redesign, testing, and requalification costs. Future supplier selection will thus consider not just price, performance, and lead time, but also intellectual property stability.
Strategic Assessment
The competition in wide-bandgap semiconductors has expanded beyond wafers, yield, cost, and customers. It now crucially involves the ability to convert patents into injunctions and those injunctions into market leverage. The GaN patent war is just beginning. Its core lesson for all semiconductor companies is that technology determines product potential, but patents determine market access. In the global semiconductor arena, no market is inherently safe, and no company can compete successfully on technology alone without a robust intellectual property strategy.
Comments